PL1988786T3 - Mieszanka oligosacharydowa - Google Patents

Mieszanka oligosacharydowa

Info

Publication number
PL1988786T3
PL1988786T3 PL07704502T PL07704502T PL1988786T3 PL 1988786 T3 PL1988786 T3 PL 1988786T3 PL 07704502 T PL07704502 T PL 07704502T PL 07704502 T PL07704502 T PL 07704502T PL 1988786 T3 PL1988786 T3 PL 1988786T3
Authority
PL
Poland
Prior art keywords
galβ1
4glc
3galβ1
6galβ1
oligosaccharide
Prior art date
Application number
PL07704502T
Other languages
English (en)
Inventor
Norbert Sprenger
François Morgan
Rafael Berrocal
Marcel Braun
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36501918&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1988786(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PL1988786T3 publication Critical patent/PL1988786T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pediatric Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
PL07704502T 2006-02-10 2007-02-09 Mieszanka oligosacharydowa PL1988786T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06101556 2006-02-10
PCT/EP2007/051288 WO2007090894A1 (en) 2006-02-10 2007-02-09 Oligosaccharide mixture
EP07704502.9A EP1988786B2 (en) 2006-02-10 2007-02-09 Oligosaccharide mixture

Publications (1)

Publication Number Publication Date
PL1988786T3 true PL1988786T3 (pl) 2010-10-29

Family

ID=36501918

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07704502T PL1988786T3 (pl) 2006-02-10 2007-02-09 Mieszanka oligosacharydowa

Country Status (15)

Country Link
US (1) US8361530B2 (pl)
EP (1) EP1988786B2 (pl)
CN (1) CN101400267B (pl)
AT (1) ATE468027T1 (pl)
AU (1) AU2007213677B2 (pl)
BR (1) BRPI0707620A2 (pl)
CA (1) CA2641842A1 (pl)
DE (1) DE602007006635D1 (pl)
ES (1) ES2342625T5 (pl)
MY (1) MY146109A (pl)
PL (1) PL1988786T3 (pl)
PT (1) PT1988786E (pl)
RU (1) RU2430631C2 (pl)
WO (1) WO2007090894A1 (pl)
ZA (1) ZA200807763B (pl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
WO2009033011A1 (en) * 2007-09-07 2009-03-12 Children's Hospital Medical Center Use of secretor, lewis and sialyl antigen levels as predictors for disease
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
EP2143341A1 (en) 2008-07-08 2010-01-13 Nestec S.A. Nutritional Composition Containing Oligosaccharide Mixture
CA2752800C (en) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
IT1394503B1 (it) 2009-04-06 2012-07-05 Inalco Spa Sali di 6'-sialillattosio e processo per la loro sintesi e per la sintesi di altri alfa-sialiloligosaccaridi.
AU2015306339A1 (en) 2014-08-18 2016-12-15 Société des Produits Nestlé S.A. Prebiotics for reducing the risk of obesity later in life
US9848760B2 (en) * 2009-06-29 2017-12-26 Gearbox, Llc Devices for continual monitoring and introduction of gastrointestinal microbes
EP3248605A1 (en) 2009-07-06 2017-11-29 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
IT1395068B1 (it) * 2009-08-07 2012-09-05 Inalco Spa Processo per la produzione di galatto-oligosaccaridi ultrapuri
US9237764B2 (en) 2010-02-19 2016-01-19 Glycom A/S Production of 6′-O-sialyllactose and intermediates
EP2455387A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2526784A1 (en) * 2011-05-24 2012-11-28 Nestec S.A. Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
EP2768311B2 (en) 2011-10-18 2025-05-28 Société des Produits Nestlé S.A. Composition for use in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
CN103889240B (zh) * 2011-10-18 2016-09-14 雀巢产品技术援助有限公司 用于增加胰岛素敏感性和/或降低胰岛素抵抗性的组合物
WO2013057063A1 (en) 2011-10-18 2013-04-25 Nestec S.A. Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
WO2013057072A1 (en) * 2011-10-18 2013-04-25 Nestec S.A. Composition for use in the promotion of magnesium absorption and/or magnesium retention
BR112014008944B1 (pt) * 2011-10-18 2020-09-15 Société des Produits Nestlé S.A. Composição nutricional simbiótica compreendendo lc-pufa, probiótico e mistura de oligossacarídeos para crescimento cerebral e/ou desenvolvimento cognitivo e/ou psicomotor
RU2484828C1 (ru) * 2012-04-11 2013-06-20 Анна Викторовна Филимонова Витаминно-минеральное средство: порошок для приготовления раствора для внутреннего применения
US20150182549A1 (en) * 2012-06-22 2015-07-02 Glycom A/S Method for enzymatic glycosylation of oligosaccharides from mammalian animal milk
WO2013190529A1 (en) * 2012-06-22 2013-12-27 Glycom A/S Glycosylated galactosyl disaccharddes, methods for their production and their use in consumable products
WO2014130789A1 (en) 2013-02-21 2014-08-28 Children's Hospital Medical Center Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
US10357506B2 (en) * 2013-11-15 2019-07-23 Nestec S.A. Compositions for use in the prevention or treatment of URT infections in infants or young children at risk
MX374247B (es) 2013-12-16 2025-03-05 Soc Des Produits Nestle S A Star Peptidos identificados recientemente para el uso en la induccion de la tolerancia oral en mamiferos jovenes.
US20170000810A1 (en) 2013-12-19 2017-01-05 Nestec S.A. Nutritional composition to reduce metabolic stress in infants
EP2885977A1 (en) * 2013-12-19 2015-06-24 Agriculture and Food Development Authority (TEAGASC) An oligosaccharide-enriched composition having immune-modulatory and anti-adhesion properties
US10857167B2 (en) 2015-04-28 2020-12-08 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
AU2016274718B2 (en) 2015-06-12 2021-01-21 Société des Produits Nestlé S.A. Combination of tolerogenic peptides and TGF-β for use in the induction and maintenance of oral tolerance in young mammals
EP3481231B1 (en) * 2016-07-11 2021-12-01 Proliant Dairy, Inc. Process for making galacto-oligosaccharide product
BR112019001181A2 (pt) 2016-08-05 2019-04-30 Nestec S.A. composição de lipídios para uso em bebês e crianças pequenas para promover conforto intestinal e ótima absorção de gordura e cálcio
WO2018053535A1 (en) * 2016-09-19 2018-03-22 Prolacta Bioscience, Inc. Purified human milk oligosaccharides compositions
MX2021006182A (es) 2018-12-19 2021-06-18 Nestle Sa Composicion para prevenir o reducir la perdida de agua transepidermica y mejorar la funcion de barrera de la piel.
KR20220066904A (ko) 2019-09-24 2022-05-24 프롤랙타 바이오사이언스, 인코포레이티드 염증 및 면역 질환의 치료용 조성물 및 방법
AU2020369082A1 (en) 2019-10-22 2022-04-14 Societe Des Produits Nestle S.A. a2-β-casein containing composition for promoting an improved temperament in young mammals

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045854A (en) 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
NL1010770C2 (nl) 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
WO2001067702A1 (en) * 2000-03-07 2001-09-13 Vyyo, Ltd. Adaptive downstream modulation scheme for broadband wireless access systems
WO2003059924A1 (en) 2002-01-18 2003-07-24 Biotie Therapies Corporation Novel binding epitopes for helicobacter pylori and use thereof
EP2272522B1 (en) * 2002-06-28 2017-09-06 Nestec S.A. Therapeutic compositions for use in prophylaxis or treatment of diarrheas
WO2005000040A1 (en) * 2003-06-24 2005-01-06 University Of Kansas Medical Center Infant formula
DE602004006133T3 (de) 2003-06-30 2014-12-24 Clasado Inc. Neue galactooligosaccharidzusammensetzung und herstellung davon
NZ546785A (en) * 2003-10-24 2009-07-31 Nutricia Nv Immunemodulating oligosaccharides
AU2006215603A1 (en) 2005-02-21 2006-08-24 Nestec S.A. Oligosaccharide mixture
PL1993576T3 (pl) 2006-03-07 2016-04-29 Nestec Sa Mieszanina synbiotyczna

Also Published As

Publication number Publication date
AU2007213677A1 (en) 2007-08-16
CN101400267A (zh) 2009-04-01
EP1988786B1 (en) 2010-05-19
RU2430631C2 (ru) 2011-10-10
AU2007213677B2 (en) 2012-04-05
BRPI0707620A2 (pt) 2011-05-10
US8361530B2 (en) 2013-01-29
PT1988786E (pt) 2010-06-22
US20090092729A1 (en) 2009-04-09
ES2342625T3 (es) 2010-07-09
EP1988786B2 (en) 2019-10-09
CA2641842A1 (en) 2007-08-16
ES2342625T5 (es) 2020-05-07
WO2007090894A1 (en) 2007-08-16
ZA200807763B (en) 2009-11-25
MY146109A (en) 2012-06-29
ATE468027T1 (de) 2010-06-15
EP1988786A1 (en) 2008-11-12
RU2008136419A (ru) 2010-03-20
DE602007006635D1 (en) 2010-07-01
CN101400267B (zh) 2011-11-23

Similar Documents

Publication Publication Date Title
ZA200807763B (en) Oligosaccharide mixture
MY149913A (en) Synbiotic mixture
EP2489280A3 (en) Synbiotic to improve gut microbiota
PH12019500518A1 (en) Oligosaccharide mixture and food product comprising this mixture, especially infant formula
WO2010023422A8 (en) Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation
MY184985A (en) Oligosaccharide mixture and food product comprising this mixture, especially infant formula
WO2008073174A3 (en) Antimicrobial therapy
EA201101189A1 (ru) Ингибитор sglt-2, предназначенный для лечения сахарного диабета типа 1, сахарного диабета типа 2, нарушенной толерантности к глюкозе или гипергликемии
MY147247A (en) Organic compounds and their uses
MY155717A (en) Nutritional composition containing oligosaccharide mixture
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
AU2008232453A8 (en) Methods and compositions for reduction of side effects of therapeutic treatments
GB0504857D0 (en) Novel compounds and their effects on feeding behaviour
WO2005119627A3 (en) Personal nutrition control devices
WO2009040445A3 (en) Arabinoxylo-oligosaccharides useful against gastrointestinal infections
TN2011000482A1 (en) Organic compounds and their uses
MY159514A (en) Composition comprising 1, 3/1, 6 beta glucan for reducing weight
ATE441333T1 (de) Zusammensetzung enthaltend oligosaccharide als lísliche ballaststoffe zur verwendung gegen muskelschwund
MX2010007033A (es) Compuestos para el tratamiento selectivo del componente inmunoinflamatorio intestinal de la enfermedad celiaca.
ATE534652T1 (de) Phosphono-pent-2-en-1-yl-nukleoside und analoga
TNSN05065A1 (en) Use of prebiotics for the treatment and prevention of hyperglycaemic syndromes
MY146657A (en) Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas
ZA200502464B (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome.
MX2008008157A (es) Control de sindromes inflamatorios intestinales con una preparacion de bacterias exterminadas o no infecciosas.
EP1968645A4 (en) HUMAN GLP-1 MIMETIC BODIES AND COMPOSITIONS FOR THE TREATMENT OF ADIPOSITAS AND RELATED DISEASES, METHODS AND APPLICATIONS